Medical Research in China Industry Research Report – Now Available from IBISWorld

Share Article

In 2012, the Medical Research industry in China is expected to generate $6.8 billion. Currently, over half of industry revenue is derived from government funding but more research institutions are expected to restructure into for-profit enterprises or establish their own enterprises in the next five years.

IBISWorld industry market research
More non-profit medical research institutions will convert to for-profit as the industry develops.

In 2012, the Medical Research industry in China is expected to generate $6.8 billion. Annualized growth over the past five years period has been about 14.3%. Over half of industry revenue is derived from government funding.

The Medical Research industry is beginning to mature and competition for government funds and private funds has increased. IBISWorld estimates that profitability is low in 2012 due to the high costs for medical research and commercialization difficulties. Profitability varies among different participants in the industry, however. Biotechnology companies tend to be profitable, while medical research institutes are more likely to suffer losses.

In 2012, the combined market share of the top four companies in the Medical Research industry in China – Chinese Academy of Sciences, WuXi AppTec, Shanghai Institute of Pharmaceutical Industry, and the Academy of Military Medical Sciences – is estimated at 19.7%. This low concentration level is due to the existence of a large number of non-profit medical research institutions and small-scale biotechnology companies. Non-profit medical research institutions rely heavily on government funding.

With increasing importance attached to research and development, the Medical Research industry in China is expected to develop steadily over the next five years. More research institutions are expected to restructure into for-profit enterprises or establish their own enterprises. Further, biotechnology companies will continue to increase in size, says IBISWorld.

For more information, visit IBISWorld’s Medical Research in China industry report page.

Follow IBISWorld on Twitter: https://twitter.com/#!/IBISWorld
Friend IBISWorld on Facebook: http://www.facebook.com/pages/IBISWorld/121347533189

IBISWorld Industry Report Key Topics

The Medical Research industry in China is engaged in basic and applied research and development in the medical and pharmaceutical fields. Enterprises include laboratories of medical research institutes, medical schools and biotech firms. The following research functions are not included in the industry: R&D activities by pharmaceutical or medical equipment manufacturing industries; research unrelated to the human body or human diseases; and the commercialization of medical research.

Industry Performance
Executive Summary
Key External Drivers
Current Performance
Industry Outlook
Industry Life Cycle
Products & Markets
Supply Chain
Products & Services
Major Markets
Globalization & Trade
Business Locations
Competitive Landscape
Market Share Concentration
Key Success Factors
Cost Structure Benchmarks
Barriers to Entry
Major Companies
Operating Conditions
Capital Intensity
Key Statistics
Industry Data
Annual Change
Key Ratios

About IBISWorld Inc.
Recognized as the nation’s most trusted independent source of industry and market research, IBISWorld offers a comprehensive database of unique information and analysis on every US industry. With an extensive online portfolio, valued for its depth and scope, the company equips clients with the insight necessary to make better business decisions. Headquartered in Los Angeles, IBISWorld serves a range of business, professional service and government organizations through more than 10 locations worldwide. For more information, visit http://www.ibisworld.com or call 1-800-330-3772.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Gavin Smith
IBISWorld
310 866 5042
Email >
Visit website